Continuing Education in Anaesthesia, Critical Care & Pain Advance Access originally published online on May 4, 2009
Continuing Education in Anaesthesia, Critical Care & Pain 2009 9(3):87-91; doi:10.1093/bjaceaccp/mkp014
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2009]. Published by Oxford University Press on behalf of The Board of Directors of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournal.org
Severe community-acquired pneumonia
Specialist Registrar
Department of Anaesthesia and Intensive Care
University Hospital of North Staffordshire
Newcastle Road
Stoke on Trent ST4 6QG
UK
Consultant in Intensive Care Medicine
Department of Anaesthesia and Intensive Care
University Hospital of North Staffordshire
Newcastle Road
Stoke on Trent ST4 6QG
UK
Tel: +44 1782 553580
Fax: +44 1782 552893
E-mail: bryan.carr@uhns.nhs.uk (for correspondence)
| The first 150 words of the full text of this article appear below. |
Key points
|
Severe community-acquired pneumonia (CAP) is an increasingly common reason for admission to the intensive care unit (ICU).1 It is associated with significant morbidity, mortality, and utilization of health service resources. Inability to differentiate between CAP and non-pneumonic lower respiratory tract infections such as acute exacerbation of chronic obstructive pulmonary disease (COPD) has led to overtreatment, with a dramatic increase in the use of broad-spectrum antibiotics. This is associated with an increase in costs and side-effects, particularly Clostridium difficile-associated diarrhoea. A reduction in the frequency of Streptococcus pneumoniae infection has been associated with a
| Definition |
|---|
| Epidemiology |
|---|
| Aetiology |
|---|
Streptococcus pneumoniae
Legionella pneumophila
Staphylococcus aureus
Atypical pathogens
| Clinical features |
|---|
| Investigations |
|---|
General
Microbiology
Radiology
Severity assessment
Pneumonia severity index5
CURB-65 score6
| Management |
|---|
Immediate ABCD approach
General
Respiratory
Antibiotic therapy
| Complications |
|---|
Pulmonary
Other
| Role of vaccination |
|---|
Influenza vaccine
Pneumococcal vaccine
| Recent advances: role of activated protein C |
|---|
| Summary |
|---|